Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases
- 1 May 1991
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 283 (3) , 162-166
- https://doi.org/10.1007/bf00372056
Abstract
It has been shown that acne, hyperpigmentation and lentigo malignant are more or less related pathogenetically to reactive oxygen species (ROS). It has recently been reported that azelaic acid is effective in treating these conditions and that it possesses anti-enzymatic and anti-mitochondrial activity, including cytochrome-P450 reductase and 5α-reductase in microsomal preparations with nicotinamide adenine dinucleotide phosphate (NADPH). We therefore investigated the effects of azelaic acid on human neutrophil functions, such as chemotaxis, phagocytosis and ROS generation. ROS generation in a cell-free system was also assessed. The results revealed that neutrophil chemotaxis and phagocytosis as well as ROS generated in a xanthine — xanthine-oxidase system were not significantly changed in the presence of azelaic acid. However, azelaic acid markedly decreased O 2 − and OH generated by neutrophils. It may be concluded that the reported clinical effectiveness of azelaic acid is partly due to its inhibitory action on neutrophil-generated ROS, leading to a reduction both in oxidative tissue injury at sites of inflammation and in melanin formation.Keywords
This publication has 37 references indexed in Scilit:
- The effect of superoxide dismutase and catalase on radiation-induced chromosome breaksHereditas, 2009
- Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: Cross-sectional and longitudinal studiesLife Sciences, 1989
- Azelaic acidJournal of the American Academy of Dermatology, 1987
- Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracyclineBritish Journal of Dermatology, 1986
- Anti-oxidant action of metronidazole: a possible mechanism of action in rosaceaBritish Journal of Dermatology, 1986
- What Does Epidermal Growth Factor Do and How Does It Do It?Journal of Investigative Dermatology, 1985
- Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritisThe Journal of Pediatrics, 1984
- Inhibition of Tumor Promotion by a Biomimetic Superoxide DismutaseScience, 1983
- MODIFICATION OF ZYMOSAN-INDUCED RELEASE OF LYSOSOMAL ENZYMES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY CYTOCHALASIN BThe Journal of cell biology, 1974
- The microestimation of succinate and the extinction coefficient of cytochrome cBiochimica et Biophysica Acta, 1959